1. Home
  2. IMUX vs CCG Comparison

IMUX vs CCG Comparison

Compare IMUX & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • CCG
  • Stock Information
  • Founded
  • IMUX 2016
  • CCG 2014
  • Country
  • IMUX United States
  • CCG China
  • Employees
  • IMUX N/A
  • CCG N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • CCG
  • Sector
  • IMUX Health Care
  • CCG
  • Exchange
  • IMUX Nasdaq
  • CCG Nasdaq
  • Market Cap
  • IMUX 102.2M
  • CCG 87.9M
  • IPO Year
  • IMUX N/A
  • CCG N/A
  • Fundamental
  • Price
  • IMUX $1.09
  • CCG $0.85
  • Analyst Decision
  • IMUX Strong Buy
  • CCG
  • Analyst Count
  • IMUX 7
  • CCG 0
  • Target Price
  • IMUX $12.67
  • CCG N/A
  • AVG Volume (30 Days)
  • IMUX 555.7K
  • CCG 625.5K
  • Earning Date
  • IMUX 05-07-2025
  • CCG 03-28-2025
  • Dividend Yield
  • IMUX N/A
  • CCG N/A
  • EPS Growth
  • IMUX N/A
  • CCG N/A
  • EPS
  • IMUX N/A
  • CCG N/A
  • Revenue
  • IMUX N/A
  • CCG $475,831,129.00
  • Revenue This Year
  • IMUX N/A
  • CCG N/A
  • Revenue Next Year
  • IMUX N/A
  • CCG $1.24
  • P/E Ratio
  • IMUX N/A
  • CCG N/A
  • Revenue Growth
  • IMUX N/A
  • CCG 5.20
  • 52 Week Low
  • IMUX $0.92
  • CCG $0.56
  • 52 Week High
  • IMUX $2.11
  • CCG $3.81
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 46.81
  • CCG 39.73
  • Support Level
  • IMUX $1.18
  • CCG $0.89
  • Resistance Level
  • IMUX $1.28
  • CCG $1.26
  • Average True Range (ATR)
  • IMUX 0.07
  • CCG 0.11
  • MACD
  • IMUX -0.00
  • CCG -0.02
  • Stochastic Oscillator
  • IMUX 6.00
  • CCG 13.54

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About CCG Cheche Group Inc.

Cheche Group Inc is an insurtech company. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, green auto insurance innovations, etc.

Share on Social Networks: